Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea
· Delayed Price · Currency is KRW 2,390.00
-40.00 (-1.65%)
At close: Apr 28, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 185.83 billion as of April 28, 2026. Its market cap has decreased by -40.22% in one year.
Market Cap
185.83B
Enterprise Value
269.19B
Revenue
19.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,390.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 185.83B, a decrease of -69.70%. That is a compound annual growth rate of -20.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 185.83B | -21.25% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ensol Biosciences | 192.35B |
| ISU Abxis | 201.81B |
| Genome & Company | 212.85B |
| ABION | 224.80B |
| ViGenCell | 229.59B |
| QuadMedicine | 151.91B |
| CORESTEMCHEMON | 141.95B |
| Bio Solution | 285.65B |